Back to
BlackRock, Inc.
CRVS8 quarters
Position history for
BlackRock, Inc.'s holdings in CORVUS PHARMACEUTICALS INC
Yes. BlackRock holds 7,138,811 shares of CRVS (Corvus Pharmaceuticals), worth $106.7M, as of its Q2 2026 13F filing. It increased the position by 978,389 shares (+15.9%) from Q1 2026. BlackRock has held CRVS in every 13F on record since Q3 2024, 8 quarterly filings.
Current Value
$106.7M
Current Shares
7.1M
Total Value Change
+$103.5M
Total Shares Change
+6.5M
Quarter-by-Quarter History
Other major holders of CRVS: STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD CAPITAL MANAGEMENT LLC, Point72 Asset Management, L.P.